April 26 (Reuters) - Karo Pharma AB:
* KARO PHARMA DOUBLES SALES AND EARNINGS IN THE FIRST QUARTER
* Q1 NET SALES AMOUNTED TO MSEK 267.1 (139.3), EQUIVALENT TO AN INCREASE OF 91.7%
* Q1 EBITDA AMOUNTED TO MSEK 88.7 (43.7) Source text for Eikon: Further company coverage: (Reporting By Stockholm newsroom)